Vilin Bio Med voluntarily filed its Integrated Corporate Governance Report for the quarter ended September 30, 2026, despite being exempt as an NSE Emerge listed entity. No material business transaction or decision is disclosed.
Vilin Bio Med Limited submitted a non-applicability certificate for the Annual Secretarial Compliance Report. The company is exempt from Regulation 24A as an SME-listed entity.
Vilin Bio Med Limited filed its annual SDD Compliance Certificate for the financial year ended March 31, 2026. The certification confirms full regulatory database compliance.
Vilin Bio Med Limited promoters have submitted an annual declaration confirming that no shares were encumbered, directly or indirectly, during the financial year ended March 31, 2026. This disclosure is a standard regulatory requirement under SEBI SAST Regulations to maintain transparency regarding promoter shareholdings.